Physician

Mark Grogan Tusa, MD

According to 2025 Medicare claims, Mark Tusa, MD (NPI: 1033395074) practices dermatology in the Chattanooga, TN-GA market, with the plurality of this provider's patient population coming from Hamilton, TN. This provider's primary affiliated billing organization is CHATTANOOGA SKIN & CANCER CLINIC (NPI: 1447343694; TIN: 621054696) and primary practice location at 37421-1616. Tusa is affiliated with the CommonSpirit ACO III (ACO ID: A2645) and Main Street Rural Health Cedar ACO LLC (ACO ID: A5502), participating under the MSSP model.

Tusa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,704 traditional Medicare patients, billed 13,653 HCPCS/CPT codes, and received $1,390,235 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 5,038 prescription claims across 1,616 beneficiaries totaling $1,141,012 in drug costs, led by Cimzia (2 Pack) (Certolizumab Pegol). Open Payments data shows 69 records totaling $1,401. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $286,837 to $1,141,012. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,453	17,678	$1,058,903
2016	2,541	16,619	$1,063,389
2017	2,289	15,552	$991,785
2018	2,384	17,548	$1,049,722
2019	2,106	16,197	$1,121,602
2020	1,919	11,996	$861,283
2021	1,932	12,955	$903,615
2022	1,840	11,700	$918,611
2023	1,840	12,984	$1,075,977
2024	1,704	13,653	$1,390,235

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,122	3,219	$286,837
2016	1,324	3,866	$314,962
2017	1,447	4,407	$409,444
2018	1,434	4,209	$618,023
2019	1,513	4,478	$666,402
2020	1,425	4,282	$965,880
2021	1,477	4,439	$1,065,034
2022	1,531	4,552	$979,849
2023	1,683	4,856	$1,271,861
2024	1,616	5,038	$1,141,012

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	590	760	$68
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,417	2,730	$58
11102	Biopsy of related skin growth, first growth	496	652	$52
17000	Destruction of precancer skin growth, 1 growth	471	654	$31
88305	Pathology examination of tissue using a microscope, intermediate complexity	576	1,296	$24

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cimzia (2 Pack)	Certolizumab Pegol	15	420	$168,144
Dupixent Pen	Dupilumab	41	1,148	$152,610
Rinvoq	Upadacitinib	15	450	$91,881
Otezla	Apremilast	13	570	$90,523
Thalomid	Thalidomide	12	336	$58,859

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	69	$1,401	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark Grogan Tusa, MD?

Tedicare shows public-source Medicare data for Mark Grogan Tusa, MD (NPI 1033395074), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Grogan Tusa, MD have ACO affiliation data?

Mark Grogan Tusa, MD is shown with ACO affiliation data for CommonSpirit ACO III (MSSP, ACO ID A2645) and Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502).

What billing organization is linked to Mark Grogan Tusa, MD?

Mark Grogan Tusa, MD is linked to CHATTANOOGA SKIN & CANCER CLINIC (billing NPI 1447343694) in the available physician profile data.

Does Mark Grogan Tusa, MD have Open Payments data?

Mark Grogan Tusa, MD has 69 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.